ADC Therapeutics
Develops proprietary antibody drugs targeting cancer
Total raised
€109M
€109,090,908
Funding rounds
2
Investors
0
distinct backers
Active since
2013-09
latest 2015-08
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood17
base rate 38% for Growth/Late
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood20
base rate 12% (2+ rounds)
- ▲ €100M+ raised
- ▲ 15y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-09-01 | Growth/Late | €73M | — | View deal → |
| 2013-10-01 | Growth/Late | €36M | — | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy